StockDuty ← Dashboard Oct 24, 2026 01:47 PM ET
SignalCorporate

Clinical trial saves man initially given weeks to live: "Not done yet"

Clinical trial success story signals positive medical research outcome.

What happened: Ryan Goepel, diagnosed with adverse-risk acute myeloid leukemia, entered remission after joining a clinical trial testing two medications typically given to older AML patients on younger patients. Key numbers: 25 of 36 trial patients saw their cancer shrink or disappear during a 28-day course, with 19 entering complete remission. Why it matters: The trial results, published in Haematologica, are generating questions about whether the decades-long standard approach to treating these patients should change, according to Dr. Mihir A. Shukla.
Ryan Goepel, diagnosed with adverse-risk acute myeloid leukemia, entered remission after joining a clinical trial testing two medications typically given to older AML patients on younger patients.
The trial results, published in Haematologica, are generating questions about whether the decades-long standard approach to treating these patients should change, according to Dr. Mihir A. Shukla.
Sources